Palantir Just Became Almost Impossible to Replace (This Changes EVERYTHING for the Stock)

Get Thomas Hughes' FREE list of 7 stocks that could be bigger than today's AI winners: https://www.marketbeat.com/y/yt983/

Palantir just signed a major new deal with the US Army, and MarketBeat analyst Chris Markoch says it's proof the company is becoming nearly impossible to replace. The contract, split with Andoril and coordinated with L3 Harris, entrenches Palantir even deeper as a battlefield system integrator for the US military... and once a company drops Palantir, they lose the entire ontology built on top of it. There's no clean way to walk away.

Chris breaks down why the stock jumped roughly 30% after August earnings, what Alex Carp's sovereign AI pitch actually means in practice, and the discounted cash flow math behind Carp's $15-18 billion free cash flow target... including why hitting that number in the next two years could justify Palantir's valuation even if growth slows down after that.

We also get into the bull and bear case on Carp as a salesman, why commercial customers who adopt Palantir tend to expand their usage rather than leave, and what this all means for Palantir's next two to ten years.

Video Chapters

00:00 Introduction

07:31 The DCF math behind Palantir's valuation

12:25 The new Army contract, explained

19:13 Why Palantir is becoming irreplaceable

View Bridget's Buys here: https://www.marketbeat.com/bridget

📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks.

DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.